To address these challenges, this vertically integrated project used cultured Schwann cells (SC) and arachnoidal cells (AC), in some cases genetically manipulated to inactivate or suppress merlin expression, to create a comprehensive cell assay system representing both schwannoma and meningioma. This evidence concerns the gene NF2 and schwannoma.